Skip to main content

Mi Suk Kim

Seoul National University · Medicine

About the Lab

Professor Mi Suk Kim's research lab specializes in stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC), focusing on optimizing dose fractionation, evaluating treatment efficacy, and assessing toxicity—particularly in patients with hepatitis B-related HCC. The lab conducts multicenter clinical trials and prospective studies to establish SBRT as a safe and effective alternative for inoperable or treatment-refractory HCC. Additional research explores molecular mechanisms of anticancer agents like emodin in glioma cells, highlighting a translational interest in cancer therapeutics. The lab also contributes to prenatal imaging, particularly 3D/4D ultrasound for early fetal brain development and congenital anomaly detection.

stereotactic body radiotherapyhepatocellular carcinomatreatment toxicitymolecular oncologyprenatal ultrasound

Research Overview

Papers
275
Total Citations
5,211
Papers (5y)
44
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
44total
2022
2023
2024
2025
2026
Citations per year (5y)
381total
20222023202420252026

Selected Papers

15
1
Article|226 citations·2013
High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
Won Il Jang, Mi‐Sook Kim, Sun Hyun Bae, Chul Koo Cho, Hyung Jun Yoo, Young Seok Seo, Jin-Kyu Kang, So Young Kim, Dong Han Lee, Chul Ju Han, Jin Kim, Su Cheol Park
SJR Q1Radiation OncologyOA

BACKGROUND: Recent studies using stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) have reported high tumor response and local control. However, the optimal SBRT dose remains unknown, and it is still not clear whether a dose response relationship for local control (LC) and overall survival (OS) exist or not. We performed this study to determine whether a dose response relationship for LC and OS is observed in SBRT for inoperable HCC. METHODS: Between 2003 and 2011, 108 pat

HepatologyMedicine
2
Article|143 citations·2010
Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma
Young Seok Seo, Mi‐Sook Kim, Sung Yul Yoo, Chul Koo Cho, Chul Won Choi, Jin Ho Kim, Chul Ju Han, Su Cheol Park, Byung Hee Lee, Young Han Kim, Dong Han Lee
SJR Q1Journal of Surgical Oncology

BACKGROUND AND OBJECTIVES: To evaluate the toxicity and efficacy of stereotactic body radiotherapy (SBRT) for the treatment of localized hepatocellular carcinoma (HCC) in the absence of another standard treatment option. METHODS: The authors reviewed the details of 38 patients with inoperable HCC (diameter <10 cm) treated by SBRT in a prospectively registered database at their institution. All patients had been treated by transcatheter arterial chemoembolization before SBRT, which had been final

HepatologyMedicine
3
Article|118 citations·2019
A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy
Won Il Jang, Sun Hyun Bae, Mi‐Sook Kim, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Eung‐Ho Cho, Chul Won Choi, Kyung Su Kim, Sangyoun Hwang, Jin Ho Kim, Ah Ram Chang
SJR Q1Cancer

BACKGROUND: Although several prospective studies have reported the efficacy of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC), treatment-related toxicity varies and has not been determined. Therefore, the authors evaluated the safety and efficacy of SBRT for patients with HCC in a hepatitis B virus-endemic area. METHODS: This multicenter phase 2 trial enrolled patients with unresectable HCC. Patients received SBRT with 45 to 60 Gy in 3 fractions. To evaluate gastroduode

HepatologyMedicine
4
Review|84 citations·2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joohyun Chung, Eunji Kim, Jin-Kyu Kang, Won Il Jang, Ji Eun Moon, Isaure Roquette, X. Mirabel, Tomoki Kimura, Masayuki Ueno, Ting‐Shi Su
SJR Q1International Journal of Radiation Oncology*Biology*PhysicsOA
HepatologyMedicine
5
Article|79 citations·2012
Predictor of Severe Gastroduodenal Toxicity After Stereotactic Body Radiotherapy for Abdominopelvic Malignancies
Sun Hyun Bae, Mi‐Sook Kim, Chul Koo Cho, Jin-Kyu Kang, Sang-Yeob Lee, Kyung-Nam Lee, Dong Han Lee, Chul Ju Han, Ki Young Yang, Sang Bum Kim
SJR Q1International Journal of Radiation Oncology*Biology*Physics
RadiationPhysics and Astronomy
6
Article|72 citations·2009
Stereotactic body radiotherapy for isolated paraaorticlymph node recurrence from colorectal cancer
Mi‐Sook Kim, Chul Koo Cho, Kwangmo Yang, Dong Han Lee, Sun Mi Moon, Young Joo Shin
SJR Q1World Journal of GastroenterologyOA

This pilot study suggests selected paraaortic lymph node recurrence (1-3 closed lesions) that failed to respond to chemotherapy can be potentially salvaged by stereotactic body radiotherapy.

HepatologyMedicine
7
Article|68 citations·2005
Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Mi Suk Kim, Myung Jin Park, So Jeong Kim, Chang Hun Lee, Heon Yoo, Sang Hoon Shin, Eun Sook Song, Seung Hoon Lee
PubMed

Emodin, an inhibitor of protein tyrosine kinase, possesses antiviral, immunosuppressive, anti-inflammatory and anticancer effects. In the present study, we investigated the effect of emodin on the hyaluronic acid (HA)-induced invasion of human glioma cells. Emodin significantly inhibited the HA-induced invasion through a Matrigel coated chamber, secretion of matrix metalloproteinase (MMP)-2, and HA-induced secretion of MMP-9 in glioma cells. To investigate the possible mechanisms involved in the

Plant ScienceAgricultural and Biological Sciences
8
Article|65 citations·2008
Three-Dimensional Sonographic Evaluations of Embryonic Brain Development
Mi Suk Kim, Philippe Jeanty, C. D. Turner, Bernard Benoît
SJR Q2Journal of Ultrasound in Medicine

OBJECTIVE: The purpose of this presentation is to show 3-dimensional development of the ventricles of the brain in early pregnancy, from 6 to 13 weeks, and to provide a reference for early diagnosis of central nervous system anomalies such as hydrocephalus and holoprosencephaly. METHODS: From March 2007 to August 2007, 46 patients were included. All patients had routine first-trimester 2- and 3-dimensional sonographic examinations at the same time. All cases were examined with a Voluson 730 Expe

Pediatrics, Perinatology and Child HealthMedicine
9
Article|51 citations·2015
Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins
Youn Kyoung Jeong, Mi‐Sook Kim, Ji Young Lee, Eun Ho Kim, Hunjoo Ha
SJR Q1PLoS ONEOA

The present study addressed whether the combination of metformin and ionizing radiation (IR) would show enhanced antitumor effects in radioresistant p53-deficient colorectal cancer cells, focusing on repair pathways for IR-induced DNA damage. Metformin caused a higher reduction in clonogenic survival as well as greater radiosensitization and inhibition of tumor growth of p53-/- than of p53+/+ colorectal cancer cells and xenografts. Metformin combined with IR induced accumulation of tumor cells i

Molecular BiologyBiochemistry, Genetics and Molecular Biology
10
Article|51 citations·2009
Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric Cancer
Mi‐Sook Kim, Sung Yul Yoo, Chul Koo Cho, Hyung Jun Yoo, Kwangmo Yang, Jin Kyu Kang, Dong Han Lee, Jong Inn Lee, Ho Youn Bang, Min Suk Kim, Hae Jin Kang
SJR Q2Journal of Korean Medical ScienceOA

The aim of this study was to investigate whether stereotactic body radiotherapy (SBRT) can salvage gastric cancer patients with para-aortic lymph node (PALN) recurrence. From January 2003 to December 2006, 7 patients were treated for isolated PALN recurrence from gastric cancer after curative resection. Follow up durations ranged from 19 to 33 months (median; 26 months), and SBRT doses from 45 Gy to 51 Gy (median 48 Gy) in 3 fractions. Disease progression-free and overall survivals and toxicitie

Pulmonary and Respiratory MedicineMedicine
11
Article|51 citations·2009
Complex Nanoparticle of Light-Emitting MEH-PPV with Au: Enhanced Luminescence
Mi Suk Kim, Dong Hyuk Park, Eun Hei Cho, Kyoung‐Ho Kim, Q‐Han Park, Hugeun Song, Dae-Chul Kim, Jeongyong Kim, Jinsoo Joo
SJR Q1ACS Nano

Complex nanoparticles (NPs) of poly(2-methoxy-5-(2'-ethylhexyloxy)-p-phenylene vinylene) (MEH-PPV) NP adsorbed with Au NPs (MEH-PPV/Au NPs) were fabricated through a reprecipitation method. The formation of MEH-PPV/Au NP complexes was confirmed through high-resolution transmission electron microscopy and Fourier transform infrared experiments. The laser confocal microscope photoluminescence (PL) efficiency of the complex MEH-PPV/Au single NP dramatically increased compared with that of the MEH-P

Electronic, Optical and Magnetic MaterialsMaterials Science
12
Article|44 citations·2005
Both antigen optimization and lysosomal targeting are required for enhanced anti‐tumour protective immunity in a human papillomavirus E7‐expressing animal tumour model
Mi Suk Kim, Jeong‐Im Sin
SJR Q1ImmunologyOA

DNA immunization is a new approach for cancer immune therapy. In this study, we constructed human papillomavirus (HPV) 16 E7 expression vector cassettes and then compared the abilities of these constructs to induce antitumour protection. Lysosome-targeted E7 antigens, and to a lesser degree signal sequence-conjugated and transmembrane region sequence-conjugated E7 antigens in a DNA form, displayed tumour protection significantly higher than wild-type E7 antigens. This enhanced tumour protection

ImmunologyImmunology and Microbiology
13
Article|41 citations·2012
High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell
Young-Joo Shin, Mi‐Sook Kim, Moon-Sun Kim, Joonseok Lee, Miae Kang, Jae‐Hoon Jeong
SJR Q1Cancer Biology & TherapyOA

Overexpression of high-mobility group box 2 (HMGB2) is recently reported in several malignant cancers and was correlated with poor response to preoperative chemoradiotherapy of colorectal cancer patients. To enhance the chemoradiotherapy efficacy, the biological function of HMGB2 was investigated with respect to radiation response. HMGB2 gene knockdown cells were constructed by infecting shRNA expressing lentivirus and clonogenic assay was performed to count the radiosensitivity. HMGB2 knockdown

Clinical BiochemistryBiochemistry, Genetics and Molecular Biology
14
Article|38 citations·2017
Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo
Wonwoo Kim, Mi‐Sook Kim, Hee-Jong Kim, Eun-Jin Lee, Jae‐Hoon Jeong, In Hwan Park, Youn Kyoung Jeong, Won Il Jang
SJR Q1International Journal of HyperthermiaOA

PURPOSE: Mild temperature hyperthermia (MTH) increases blood flow and oxygenation in tumours. On the other hand, high-dose-per-fraction irradiation damages blood vessels, decreases blood flow and increases hypoxia in tumours. The radiation-induced hypoxia in tumours activates hypoxia-inducible factor-1α (HIF-1α) and its target genes, such as vascular endothelial growth factor (VEGF), promoting revascularization and recurrence. In the present study, we examined the hypothesis that MTH inhibits ra

Cancer ResearchBiochemistry, Genetics and Molecular Biology
15
Article|28 citations·2013
Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies
Sun Hyun Bae, Mi‐Sook Kim, So Young Kim, Won Il Jang, Chul Koo Cho, Hyung Jun Yoo, Kum Bae Kim, Dong Han Lee, Chul Ju Han, Ki Young Yang, Sang Bum Kim
SJR Q2International Journal of Colorectal Disease
OncologyMedicine

Research Areas

HepatologyRadiationPulmonary and Respiratory MedicineSurgeryElectrical and Electronic EngineeringRadiology, Nuclear Medicine and Imaging

Dive deeper into Mi Suk Kim's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.